CardioScale Wins CTTSC3
CardioScale Wins The Combating Terrorism Technology StartUp Challange (CTTSC3) Presented by The US Department of Defence (CTTSO), Israel...
Predicting Deterioration - Saving Lives.
Our Recent Posts
Archive
Tags
Australian Patent Aproved
CardioScale Ltd. announces that the application for its proprietary CVRI Index has been approved by the Australian Authority IP...
CardioScale Patents CVRI in Asian Markets
CardioScale Ltd. Announces that its proprietary CVRI Index has been approved by both the Chinese and Japanese Patent Authorities, giving...
China Patent Granted.
CardioScale announced today that its Patent in Mainland China had successfully passed examination and was fully granted. The company...
CardioScale announces U.S patent Granted
The company specializing in early detection of hemodynamic deterioration based on its innovative technology announced today that the U.S....
Meet us at IEICI – Emergency Medicine in Paris, France | 24 – 25 April, 2017
Innovation in Emergency Medicine, Preparedness, Management & Rehabilitation. Paris – France | 24 – 25 April, 2017 Sharing the best...
CardioScale has been selected to participate in a Global Startup Program in Taipei – Taiwan | May 22
Taiwan is a country with advanced medical technology, high-efficient infrastructure, and potential aging markets nearby. In 2016...
CardioScale selected to present at the ESICM International Congress for Intensive Care Medicine in V
We are delighted to inform that CardioScale's abstract has been selected by the Congress Scientific Committee to present its studies: ...